190 related articles for article (PubMed ID: 9535891)
1. A chimeric protein C containing the prothrombin Gla domain exhibits increased anticoagulant activity and altered phospholipid specificity.
Smirnov MD; Safa O; Regan L; Mather T; Stearns-Kurosawa DJ; Kurosawa S; Rezaie AR; Esmon NL; Esmon CT
J Biol Chem; 1998 Apr; 273(15):9031-40. PubMed ID: 9535891
[TBL] [Abstract][Full Text] [Related]
2. Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C.
Rosing J; Hoekema L; Nicolaes GA; Thomassen MC; Hemker HC; Varadi K; Schwarz HP; Tans G
J Biol Chem; 1995 Nov; 270(46):27852-8. PubMed ID: 7499257
[TBL] [Abstract][Full Text] [Related]
3. Functional properties and active-site topographies of factor X Gla- and prothrombin Gla-domain chimeras of activated protein C.
Qureshi SH; Yang L; Manithody C; Bae JS; Rezaie AR
Biochim Biophys Acta; 2008 Sep; 1780(9):1080-6. PubMed ID: 18539155
[TBL] [Abstract][Full Text] [Related]
4. The second laminin G-type domain of protein S is indispensable for expression of full cofactor activity in activated protein C-catalysed inactivation of factor Va and factor VIIIa.
Evenäs P; García de Frutos P; Nicolaes GA; Dahlbäck B
Thromb Haemost; 2000 Aug; 84(2):271-7. PubMed ID: 10959700
[TBL] [Abstract][Full Text] [Related]
5. Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor VaR506Q by activated protein C.
Nicolaes GA; Tans G; Thomassen MC; Hemker HC; Pabinger I; Varadi K; Schwarz HP; Rosing J
J Biol Chem; 1995 Sep; 270(36):21158-66. PubMed ID: 7673148
[TBL] [Abstract][Full Text] [Related]
6. The effect of phospholipids, calcium ions and protein S on rate constants of human factor Va inactivation by activated human protein C.
Bakker HM; Tans G; Janssen-Claessen T; Thomassen MC; Hemker HC; Griffin JH; Rosing J
Eur J Biochem; 1992 Aug; 208(1):171-8. PubMed ID: 1387359
[TBL] [Abstract][Full Text] [Related]
7. The effect of Arg306-->Ala and Arg506-->Gln substitutions in the inactivation of recombinant human factor Va by activated protein C and protein S.
Egan JO; Kalafatis M; Mann KG
Protein Sci; 1997 Sep; 6(9):2016-27. PubMed ID: 9300501
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional specificity of the protein C/activated protein C Gla domain.
Preston RJ; Ajzner E; Razzari C; Karageorgi S; Dua S; Dahlbäck B; Lane DA
J Biol Chem; 2006 Sep; 281(39):28850-7. PubMed ID: 16867987
[TBL] [Abstract][Full Text] [Related]
9. The mechanism of inactivation of human platelet factor Va from normal and activated protein C-resistant individuals.
Camire RM; Kalafatis M; Cushman M; Tracy RP; Mann KG; Tracy PB
J Biol Chem; 1995 Sep; 270(35):20794-800. PubMed ID: 7657663
[TBL] [Abstract][Full Text] [Related]
10. The effect of membrane composition on the hemostatic balance.
Smirnov MD; Ford DA; Esmon CT; Esmon NL
Biochemistry; 1999 Mar; 38(12):3591-8. PubMed ID: 10090745
[TBL] [Abstract][Full Text] [Related]
11. The mechanism of inactivation of human factor V and human factor Va by activated protein C.
Kalafatis M; Rand MD; Mann KG
J Biol Chem; 1994 Dec; 269(50):31869-80. PubMed ID: 7989361
[TBL] [Abstract][Full Text] [Related]
12. Conversion of glutamic acid 192 to glutamine in activated protein C changes the substrate specificity and increases reactivity toward macromolecular inhibitors.
Rezaie AR; Esmon CT
J Biol Chem; 1993 Sep; 268(27):19943-8. PubMed ID: 8104182
[TBL] [Abstract][Full Text] [Related]
13. Interdomain engineered disulfide bond permitting elucidation of mechanisms of inactivation of coagulation factor Va by activated protein C.
Gale AJ; Xu X; Pellequer JL; Getzoff ED; Griffin JH
Protein Sci; 2002 Sep; 11(9):2091-101. PubMed ID: 12192065
[TBL] [Abstract][Full Text] [Related]
14. Protein C activation and factor Va inactivation on human umbilical vein endothelial cells.
Hockin MF; Kalafatis M; Shatos M; Mann KG
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2765-75. PubMed ID: 9409254
[TBL] [Abstract][Full Text] [Related]
15. Phosphatidylethanolamine incorporation into vesicles selectively enhances factor Va inactivation by activated protein C.
Smirnov MD; Esmon CT
J Biol Chem; 1994 Jan; 269(2):816-9. PubMed ID: 8288632
[TBL] [Abstract][Full Text] [Related]
16. Properties of a recombinant chimeric protein in which the gamma-carboxyglutamic acid and helical stack domains of human anticoagulant protein C are replaced by those of human coagulation factor VII.
Geng JP; Castellino FJ
Thromb Haemost; 1997 May; 77(5):926-33. PubMed ID: 9184404
[TBL] [Abstract][Full Text] [Related]
17. Construction, expression, and characterization of a chimera of factor IX and factor X. The role of the second epidermal growth factor domain and serine protease domain in factor Va binding.
Hertzberg MS; Ben-Tal O; Furie B; Furie BC
J Biol Chem; 1992 Jul; 267(21):14759-66. PubMed ID: 1634519
[TBL] [Abstract][Full Text] [Related]
18. A model describing the inactivation of factor Va by APC: bond cleavage, fragment dissociation, and product inhibition.
Hockin MF; Cawthern KM; Kalafatis M; Mann KG
Biochemistry; 1999 May; 38(21):6918-34. PubMed ID: 10346914
[TBL] [Abstract][Full Text] [Related]
19. Cardiolipin enhances protein C pathway anticoagulant activity.
Fernández JA; Kojima K; Petäjä J; Hackeng TM; Griffin JH
Blood Cells Mol Dis; 2000 Apr; 26(2):115-23. PubMed ID: 10753602
[TBL] [Abstract][Full Text] [Related]
20. Enhanced rate of cleavage at Arg-306 and Arg-506 in coagulation factor Va by Gla domain-mutated human-activated protein C.
Sun YH; Tran S; Norstrøm EA; Dahlbäck B
J Biol Chem; 2004 Nov; 279(46):47528-35. PubMed ID: 15337738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
